Skip to main content
. 2023 Apr 13;77(4):593–605. doi: 10.1093/cid/ciad219

Figure 2.

Figure 2.

Time-to-virological outcomes estimated by Kaplan-Meier curves. A. Time-to-viral blip following virological suppression. B. Time-to-low-level viremia following virological suppression. C. Time-to-residual viremia following virological suppression. D. Time-to-virological failure following virological suppression. Abbreviations: DTG, dolutegravir; DRV, darunavir; EVG, elvitegravir; FU, follow-up; LLV, low-level viremia; RAL, raltegravir; RPV, rilpivirine; RV, residual viremia; VF, virological failure; VS, virological suppression.